DZ3225A1 - METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES - Google Patents

METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES

Info

Publication number: DZ3225A1
Authority: DZ; Algeria
Prior art keywords: compositions; treatment; lung diseases; lung; diseases
Prior art date: 1999-11-02

Application number

DZ003225A

Other languages

French (fr)

Inventor

Peter N Goodfellow

Richard Nieman

Theodore J Torphy

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-02

Filing date

2000-11-01

Publication date

2001-05-10

2000-11-01 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-05-10 Application granted granted Critical

2001-05-10 Publication of DZ3225A1 publication Critical patent/DZ3225A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DZ003225A 1999-11-02 2000-11-01 METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES DZ3225A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16315899P	1999-11-02	1999-11-02
PCT/US2000/030113 WO2001032127A2 (en)	1999-11-02	2000-11-01	Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number	Publication Date
DZ3225A1 true DZ3225A1 (en)	2001-05-10

Family

ID=22588737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003225A DZ3225A1 (en)	1999-11-02	2000-11-01	METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES

Country Status (29)

Country	Link
EP (1)	EP1225866A4 (en)
JP (1)	JP2003513028A (en)
KR (1)	KR20020057988A (en)
CN (1)	CN1387404A (en)
AP (1)	AP2002002496A0 (en)
AR (1)	AR029189A1 (en)
AU (1)	AU1357501A (en)
BG (1)	BG106748A (en)
BR (1)	BR0015270A (en)
CA (1)	CA2388333A1 (en)
CO (1)	CO5261512A1 (en)
CZ (1)	CZ20021512A3 (en)
DZ (1)	DZ3225A1 (en)
EA (1)	EA200200518A1 (en)
EC (1)	ECSP003747A (en)
HK (1)	HK1049107A1 (en)
HU (1)	HUP0203152A3 (en)
IL (1)	IL149367A0 (en)
MA (1)	MA26841A1 (en)
MX (1)	MXPA02004350A (en)
NO (1)	NO20022057L (en)
OA (1)	OA12076A (en)
PE (1)	PE20011005A1 (en)
PL (1)	PL355261A1 (en)
SK (1)	SK7592002A3 (en)
TR (1)	TR200201211T2 (en)
TW (1)	TWI242431B (en)
WO (1)	WO2001032127A2 (en)
ZA (1)	ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60218497T2 (en) *	2001-09-19	2007-11-08	Nycomed Gmbh	COMBINATION OF A NSAID AND A PDE-4 INHIBITOR
EP1463509A1 (en) *	2001-10-31	2004-10-06	MERCK PATENT GmbH	Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) *	2002-08-09	2008-04-10	Меда Фарма Гмбх & Ко. Кг	Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) *	2002-10-17	2004-07-01	Ono Pharmaceutical Co	Therapeutic agent for chronic obstructive pulmonary disease
JPWO2004087149A1 (en) *	2003-03-31	2006-06-29	協和醗酵工業株式会社	Pharmaceutical composition
US20050026883A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20070287689A1 (en) *	2004-10-13	2007-12-13	Kyowa Hakko Kogyo Co., Ltd.	Therapeutic And/Or Preventive Agents For Chronic Skin Diseases
CA2626628A1 (en) *	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type iv inhibitors
CN105381524A (en)	2010-01-05	2016-03-09	微剂量治疗技术公司	Inhalation device and method
WO2015063669A1 (en)	2013-10-30	2015-05-07	Wockhardt Limited	Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0710109T3 (en) *	1993-06-18	2005-01-03	Smithkline Beecham Corp	Method of Identifying a PDE IV Inhibitor
DE4332041C2 (en) *	1993-09-21	1997-12-11	Rentschler Arzneimittel	Use of pentoxifylline in certain lung diseases
PE44995A1 (en) *	1994-01-27	1995-12-18	Schering Corp	MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) *	1998-04-20	1998-04-20	Astra Ab	New use

2000
- 2000-10-31 AR ARP000105742A patent/AR029189A1/en not_active Application Discontinuation
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/en unknown
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/en active
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/en unknown
- 2000-11-01 EA EA200200518A patent/EA200200518A1/en unknown
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en not_active Ceased
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/en unknown
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-01 PL PL00355261A patent/PL355261A1/en not_active Application Discontinuation
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 HK HK02109234.5A patent/HK1049107A1/en unknown
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/en not_active IP Right Cessation
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/en not_active Ceased
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/en unknown
- 2000-11-01 CN CN00815265A patent/CN1387404A/en active Pending
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/en unknown
- 2000-11-01 IL IL14936700A patent/IL149367A0/en unknown
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/en unknown
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/en active Pending
- 2000-11-02 CO CO00083427A patent/CO5261512A1/en not_active Application Discontinuation
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/en not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/en not_active IP Right Cessation
2002
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/en unknown
- 2002-04-30 NO NO20022057A patent/NO20022057L/en not_active Application Discontinuation
- 2002-05-02 MA MA26621A patent/MA26841A1/en unknown
- 2002-05-29 BG BG106748A patent/BG106748A/en unknown

Also Published As

Publication number	Publication date
MXPA02004350A (en)	2002-11-07
EP1225866A4 (en)	2004-04-21
HUP0203152A3 (en)	2004-06-28
CA2388333A1 (en)	2001-05-10
SK7592002A3 (en)	2002-11-06
EP1225866A2 (en)	2002-07-31
OA12076A (en)	2006-05-04
TWI242431B (en)	2005-11-01
WO2001032127A2 (en)	2001-05-10
ZA200203435B (en)	2003-06-25
TR200201211T2 (en)	2002-08-21
HK1049107A1 (en)	2003-05-02
PE20011005A1 (en)	2001-09-28
AP2002002496A0 (en)	2002-06-30
PL355261A1 (en)	2004-04-05
CO5261512A1 (en)	2003-03-31
HUP0203152A2 (en)	2003-01-28
ECSP003747A (en)	2002-05-23
AU1357501A (en)	2001-05-14
CN1387404A (en)	2002-12-25
JP2003513028A (en)	2003-04-08
BR0015270A (en)	2002-06-18
WO2001032127A3 (en)	2001-12-06
AR029189A1 (en)	2003-06-18
NO20022057L (en)	2002-06-27
IL149367A0 (en)	2002-11-10
KR20020057988A (en)	2002-07-12
MA26841A1 (en)	2004-12-20
BG106748A (en)	2003-02-28
EA200200518A1 (en)	2002-10-31
NO20022057D0 (en)	2002-04-30
CZ20021512A3 (en)	2003-04-16

Publication	Publication Date	Title
DE69509544D1 (en)	1999-06-10	COMPOSITION FOR THE TREATMENT OF OVARIAL OSTROGEN-DEPENDENT DISEASES
DE60023128D1 (en)	2006-02-23	PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES
EP1438062A4 (en)	2005-06-01	METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN LESIONS
DE60124302D1 (en)	2006-12-14	THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
MA26992A1 (en)	2004-12-20	PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
FR13C0060I2 (en)	2014-04-11	FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
DE60224163D1 (en)	2008-01-31	COMBINATIONS OF EZETIMIBE AND ASPIRIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
MA27027A1 (en)	2004-12-20	PDE4 INHIBITOR AND ASSOCIATED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
DE60123238D1 (en)	2006-11-02	COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
FIU20060389U0 (en)	2006-09-22	Treatment of bone diseases
EP1311261A4 (en)	2004-06-02	MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
DE60027290D1 (en)	2006-05-24	SCLER APROTHESIS FOR THE TREATMENT OF WEIGHTNESS AND OTHER EYE DISEASES
ATE451123T1 (en)	2009-12-15	VAGINAL ADMINISTERED COMPOSITION FOR THE TREATMENT OF UTERINE DYSRHYTHMIA
FI20011403L (en)	2002-12-30	Method and compositions for treating stomach diseases
DE60204466D1 (en)	2005-07-07	INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
ATE201992T1 (en)	2001-06-15	CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
DE50013843D1 (en)	2007-01-18	MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
HUP0302718A3 (en)	2011-03-28	Methods and compositions for the treatment of diseases of the eye
HUP0401392A3 (en)	2012-09-28	Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
DZ3225A1 (en)	2001-05-10	METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
EP1429775A4 (en)	2007-04-11	METHODS OF TREATING PULMONARY DISEASES
EP1830873A4 (en)	2008-04-02	GLYPONECTIN (ADIPONECTIN GLYCOSYLE) FOR THE TREATMENT OF DISEASES AND CONDITIONS
IL155174A0 (en)	2003-10-31	Methods and compositions for the treatment of inflammatory diseases
EP1161255A4 (en)	2002-07-17	METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSERECTION
DE60016047D1 (en)	2004-12-23	DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES